StockNews.com Initiates Coverage on IRIDEX (NASDAQ:IRIX)

StockNews.com assumed coverage on shares of IRIDEX (NASDAQ:IRIX) in a report published on Tuesday morning. The firm issued a hold rating on the medical equipment provider’s stock.

IRIDEX Price Performance

IRIDEX stock opened at $0.89 on Tuesday. The company has a market cap of $14.81 million, a P/E ratio of -1.33 and a beta of 0.94. IRIDEX has a one year low of $0.78 and a one year high of $3.65. The business has a fifty day moving average of $1.42 and a two-hundred day moving average of $1.61. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.85 and a current ratio of 1.54.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.